Cohort I baseline characteristics overall and by inclusion in the analysis of HIV diversity.

The table shows baseline demographic and clinical characteristics for children who were enrolled in Cohort I of the P1060 study and were vs. were not included in the analysis of HIV diversity (see Figure 1). P values 10 copies/mL; CD4 cell count: expressed as cells/mm3; CD4%: CD4 cell percentage; ARV: antiretroviral.aFisher's Exact Test.bWilcoxon Test.cMaternal ARV drug use during pregnancy was reported for 48 infants; 47 women had used zidovudine (three had also used lamivudine [3TC]) and 1 had used 3TC and stavudine.dTwenty of the 139 infants in this study had ARV resistance at study entry; 15 had resistance to nevirapine (NVP), two had resistance to didanosine (ddI), two had resistance to NVP and ddI, and one had resistance to 3TC and emtricitabine.